Traditional vaccines typically focus on the most accessible parts of viruses, which are often the rapidly mutating ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

Respiratory viruses are continuing to spread across the United States and such activity "is expected to continue for several ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...